生物医药ETF汇添富(159839)资产负债表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 资产 |
| 银行存款 |
- |
- |
- |
- |
| 结算备付金 |
654,399.45 |
367,885.05 |
629,140.43 |
185,908.51 |
| 存出保证金 |
68,069.28 |
50,306.87 |
44,840.39 |
28,109.15 |
| 交易性金融资产 |
712,722,158.76 |
570,872,462.98 |
552,929,437.09 |
454,803,917.94 |
| 其中:股票投资 |
712,722,158.76 |
570,872,462.98 |
552,929,437.09 |
454,803,917.94 |
| 债券投资 |
- |
- |
- |
- |
| 资产支持证券投资 |
- |
- |
- |
- |
| 衍生金融资产 |
- |
- |
- |
- |
| 买入返售金融资产 |
- |
- |
- |
- |
| 应收证券清算款 |
698,732.78 |
2,186,126.03 |
4,216,381.98 |
120,457.90 |
| 应收利息 |
- |
- |
- |
- |
| 应收股利 |
- |
- |
- |
- |
| 应收申购款 |
- |
- |
- |
- |
| 其他资产 |
- |
- |
- |
- |
| 资产总计 |
720,169,782.27 |
579,266,901.85 |
564,893,176.50 |
460,537,898.46 |
| 负 债 |
| 短期借款 |
- |
- |
- |
- |
| 交易性金融负债 |
- |
- |
- |
- |
| 衍生金融负债 |
- |
- |
- |
- |
| 卖出回购金融资产款 |
- |
- |
- |
- |
| 应付证券清算款 |
1,937,648.91 |
4,052,619.67 |
4,375,504.58 |
2,539,527.97 |
| 应付赎回款 |
- |
- |
- |
- |
| 应付管理人报酬 |
301,345.84 |
232,588.12 |
231,819.34 |
194,013.32 |
| 应付托管费 |
60,269.15 |
46,517.62 |
46,363.88 |
38,802.66 |
| 应付销售服务费 |
- |
- |
- |
- |
| 应付交易费用 |
- |
- |
- |
- |
| 应交税费 |
- |
- |
- |
103.58 |
| 应付利息 |
- |
- |
- |
- |
| 应付利润 |
- |
- |
- |
- |
| 其他负债 |
226,396.77 |
145,587.50 |
241,623.36 |
194,475.27 |
| 负债合计 |
2,525,660.67 |
4,477,312.91 |
4,895,311.16 |
2,966,922.80 |
| 所有者权益 |
| 实收基金 |
2,006,235,165.00 |
1,665,735,165.00 |
1,656,735,165.00 |
1,443,735,165.00 |
| 未分配利润 |
-1,288,591,043.40 |
-1,090,945,576.06 |
-1,096,737,299.66 |
-986,164,189.34 |
| 所有者权益合计 |
717,644,121.60 |
574,789,588.94 |
559,997,865.34 |
457,570,975.66 |
| 负债及所有者权益总计 |
720,169,782.27 |
579,266,901.85 |
564,893,176.50 |
460,537,898.46 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年